MONTGOMERY, Ala. (AP) -- The Alabama Department of Public Health says no one in Alabama has reported any adverse effects from a potentially contaminated injectable steroid from a compounding pharmacy in Tennessee.
Department official Kelley Stevens said Wednesday only one clinic in Alabama received the steroid product that is associated with the investigation, methylprednisolone acetate. It was produced at Main Street Family Pharmacy in Newbern, Tenn. Health officials aren't saying where that clinic is located in Alabama, but they say less than 100 patients received the steroid. All of those have been contacted and none has reported any symptoms.
Alabama's health department began an investigation May 24 after the U.S. Food and Drug Administration reported problems with seven patients in two states. Alabama was one of 13 states that received the drug.